Test Predicts Response to Key Migraine Therapy With 86% Accuracy
Researchers from Harvard Medical School found non-ictal cephalic allodynia, established by a quick, inexpensive and noninvasive proprietary test, is an 86% accurate pretreatment predictor of anti-calcitonin gene–related peptide (CGRP) therapy response. To read the rest of the article head over to PainMedicineNews.com
More to explorer
Mindfulness Meditation and Placebo Modulate Distinct Neural Signatures to Reduce Pain
Facebook Mindfulness meditation, which has been used for pain management in various cultures for centuries, has long been thought to work by activating
Emotional Awareness, Expression Therapy Shown to Curb Pain Severity
Facebook A randomized clinical trial’s results suggest that emotional awareness and expression therapy (EAET) “may be a preferred intervention for medically and psychiatrically complex
Psychosocial Distress May Be Best Indicator of High-Impact Chronic Pain With KOA
Facebook Data published in the Journal of Pain indicate that high-impact chronic pain (HICP) is more common among people with knee osteoarthritis (KOA)